Healthcare & Life Sciences
ProLynx
Israelprolynxinc.com/
ProLynx is a Healthcare & Life Sciences startup based in Israel, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About ProLynx
ProLynx is a company headquartered in Israel. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
ProLynx develops a hydrogel-based microsphere drug delivery platform with tunable linker chemistry to enable ultra-long-acting, extended-release therapeutics for obesity, diabetes, and related metabolic diseases, supporting dosing intervals of up to 90 days.
Explore ProLynx's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.